Search for: "Janssen Pharmaceutica, N.V."
Results 1 - 16
of 16
Sorted by Relevance
|
Sort by Date
5 Sep 2008, 8:28 am
(Apotex) appeals the order of the United States District Court for the District of New Jersey dismissing its declaratory judgment action for noninfringement against Plaintiffs-Appellees Janssen Pharmaceutica, N.V. and Janssen, L.P. [read post]
18 Aug 2008, 3:48 am
Janssen Pharmaceutica N.V. et al. v. [read post]
14 Aug 2021, 10:59 am
Janssen Pharmaceutica, N.V. [read post]
16 Apr 2012, 9:49 pm
Cir. 2008), and Janssen Pharmaceutica, N.V. v. [read post]
15 Sep 2008, 7:22 pm
More on Janssen Pharmaceutica, N.V. v. [read post]
27 Sep 2009, 2:30 pm
In Re '318 Patent Infringment Litigation: Janssen Pharmaceutica v. [read post]
5 Dec 2022, 6:55 am
The court granted Teva’s motion, finding the facts analogous to the Federal Circuit’s decision in Janssen Pharmaceutica, N.V. v. [read post]
5 Dec 2022, 6:55 am
The court granted Teva’s motion, finding the facts analogous to the Federal Circuit’s decision in Janssen Pharmaceutica, N.V. v. [read post]
5 Dec 2022, 6:55 am
The court granted Teva’s motion, finding the facts analogous to the Federal Circuit’s decision in Janssen Pharmaceutica, N.V. v. [read post]
6 Oct 2010, 4:31 pm
Cir. 2008) and Janssen Pharmaceutica, N.V. v. [read post]
23 Oct 2009, 4:12 pm
In In re ‘318 Patent Infringement Litigation (Janssen Pharmaceutica N.V. v. [read post]
6 Oct 2010, 11:43 pm
Constitution for a court to have jurisdiction in ANDA Hatch-Waxman declaratory judgment actions where a patent covering the Reference Listed Drug is listed in the Orange Book; specifically, in Caraco and another 2008 decision in Janssen Pharmaceutica, N.V. v. [read post]
27 Oct 2021, 5:15 am
Janssen Pharmaceutica, N.V., No. 21-202 (NHK-Fintiv rule for denying petitions; appealability of IPR petition denial); Apple Inc. v. [read post]
24 Jan 2012, 6:34 pm
Cir. 2008) and Janssen Pharmaceutica, N.V. v. [read post]
14 Dec 2021, 9:57 am
Janssen Pharmaceutica, N.V., No. 21-202. [read post]
17 Feb 2010, 5:10 am
(Patent Docs) Razadyne (Galantamine) / Strattera (Atomoxetine) – US: Walking the enablement/non-obviousness tightrope: Janssen Pharmaceutica N.V. v. [read post]
